Cargando…
PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429084/ http://dx.doi.org/10.1097/01.HS9.0000850880.23639.66 |
| _version_ | 1784779324226797568 |
|---|---|
| author | Paul, B. Liedtke, M. Siegel, D. S. Khouri, J. Hillenglass, J. Rifkin, R. Gandhi, M. D. Kin, A. Levy, M. Y. Mohrbacher, A. Schmidt, W. Silbermann, R. Cottini, F. Sborov, D. W. Walker, R. Murphy, M. Gu, L. Chen, A. Rajakumaraswamy, N. Usmani, S. Z. |
| author_facet | Paul, B. Liedtke, M. Siegel, D. S. Khouri, J. Hillenglass, J. Rifkin, R. Gandhi, M. D. Kin, A. Levy, M. Y. Mohrbacher, A. Schmidt, W. Silbermann, R. Cottini, F. Sborov, D. W. Walker, R. Murphy, M. Gu, L. Chen, A. Rajakumaraswamy, N. Usmani, S. Z. |
| author_sort | Paul, B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429084 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290842022-08-31 PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA Paul, B. Liedtke, M. Siegel, D. S. Khouri, J. Hillenglass, J. Rifkin, R. Gandhi, M. D. Kin, A. Levy, M. Y. Mohrbacher, A. Schmidt, W. Silbermann, R. Cottini, F. Sborov, D. W. Walker, R. Murphy, M. Gu, L. Chen, A. Rajakumaraswamy, N. Usmani, S. Z. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429084/ http://dx.doi.org/10.1097/01.HS9.0000850880.23639.66 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Paul, B. Liedtke, M. Siegel, D. S. Khouri, J. Hillenglass, J. Rifkin, R. Gandhi, M. D. Kin, A. Levy, M. Y. Mohrbacher, A. Schmidt, W. Silbermann, R. Cottini, F. Sborov, D. W. Walker, R. Murphy, M. Gu, L. Chen, A. Rajakumaraswamy, N. Usmani, S. Z. PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | pb2012: a phase 2 multiarm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429084/ http://dx.doi.org/10.1097/01.HS9.0000850880.23639.66 |
| work_keys_str_mv | AT paulb pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT liedtkem pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT siegelds pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT khourij pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT hillenglassj pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT rifkinr pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT gandhimd pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT kina pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT levymy pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT mohrbachera pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT schmidtw pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT silbermannr pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT cottinif pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT sborovdw pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT walkerr pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT murphym pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT gul pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT chena pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT rajakumaraswamyn pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma AT usmanisz pb2012aphase2multiarmstudyofmagrolimabcombinationsinpatientswithrelapsedrefractorymultiplemyeloma |